Tag Archives: applicationtime

German Government Provides Relief For RWE- But That Won’t Turn The Share Price

The planned levy on old coal plant will most likely be scrapped. RWE will see a positive impact on two sides: Most of its plant will keep running and the one that won’t will receive capacity payments. The relief bounce of the shares is justified, but the news is not enough to reverse longer term performance. The likely prospect of an absence of the coal levy is a great relief for the German generators. Contrary to previous developments, this time the biggest beneficiary is RWE ( OTCPK: OTCPK:RWEOY ). I short term relief, but prefer E.ON ( OTCQX: OTCQX:EONGY ) for longer term exposure. According to German news source ARD, the Economy Minister will drop the planned coal levy . The Ministry has said it is looking at alternative plans. Reportedly, the government is looking to mothball 2.7GW of old coal plant over a time frame of four years, in order to push forward towards its emissions reductions target. Old hard coal plant under the CHP (combined heat and power) regime would be shut first, in order to substitute that plant with gas CHP. The government would look to cover the 5.5mt shortfall against its emission reductions target through other measures, such as support for heat pumps and unspecified measures at municipalities. The Minister has said he will publish a final decision July 1st. Considering the wordings of comments by several senior government and State level officials across the coalition parties on the matter over the past couple of days, I see the likelihood as the coal levy being off the table. “Realpolitik” and industrial policy seem to have won the argument. The impact on the domestic lignite industry would have been too important to bear. Further, under energy considerations, especially security of supply and affordability, lignite is a fuel that is abundant and cheaply available from domestic sources. It is clear, that there will be another impact on affordability. The CHP repartition will increase end user prices. But so would the coal levy ad power price impact have done. Mothballing of old capacity would almost certainly hit RWE alone. It has over 7GW of coal capacity that is over 37 years old. But, on balance it might be a positive. The plant runs on very low load factors. On the other hand, the Minister has said there would be compensation for such reserve plant. RWE and Vattenfall would thus receive capacity payments. On a side note, the part of the mothballed reserve plant invites questions relating to potential capacity payments. The government has several times articulated a less than supportive position for capacity payments. And certainly, if any they might be for gas in the first instance. But these plans could be interpreted as a de facto start of a remunerated capacity reserve. With that, I see the relief bounce for RWE as justified. But we doubt that there will be any reversal of performance. For that, the structural challenges on the overall profitability of the generation business are too steep (for further detail on my fundamental views see my previous article on SA – Why RWE remains uninspiring ). Editor’s Note: This article discusses one or more securities that do not trade on a major U.S. exchange. Please be aware of the risks associated with these stocks. Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. (More…) I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Income And Caution With This Dividend ETF

Summary Dividend ETFs may generate attractive yields, but they are exposed to rate-sensitive sectors. Highlight of the First Trust Value Line Dividend Index Fund. Significant utilities sector position is weighing in on performance. By Todd Shriber & Tom Lydon With Treasury yields rising and concerns that the Federal Reserve will boost interest rates in the coming months doing the same, some dividend exchange traded funds are lagging broader benchmarks. That is true of the First Trust Value Line Dividend Index ETF (NYSEARCA: FVD ) , which has traded modestly lower this year while the S&P 500 has gained 2.5%. FVD follows the Value Line Dividend Index, which equally weights components and utilizes the proprietary Value Line research to select components. Specifically, stocks are ranked by the Value Line Safety Ranking of 1 or 2 out of 5, which are based on price stability and financial strength. Additionally, the index excludes stocks with a dividend yield lower than the S&P 500. “Over the last 10 years, FVD produced an annual average 10.4% gain vs. 7.9% for the S&P 500,” according to Investor’s Business Daily . “Their difference in their current dividend yield is modest. FVD yields 2.2% and SPY 1.9%.” Though its yield is attractive relative to the S&P 500, it is the source of that yield that could be a strike against FVD in a rising rate environment. Specifically, the ETF allocates 22.6% of its weight to utilities stocks, the most vulnerable group to rising interest rates . FVD devotes another 13.5% of its weight to consumer staples stocks, another sector that historically lags when interest rates climb. FVD’s utilities and staples exposure is somewhat offset by a combined 32.3% weight to financial services and industrials names, groups that often perform as Fed policy turns hawkish. Rising Treasury yields and slumping utilities stocks have not been enough to sour investors on FVD. The ETF is home to nearly $1.21 billion in assets under management up from $955 million in October. The ETF’s technology weight of 8.1% is fair among dividend funds, but FVD allocates less than 2% to telecom, another highly rate-sensitive sector. FVD’s holdings are also equally weighted. FVD currently shows 187 holdings and its largest component stocks only make up 0.65% of the underlying portfolio. However, this strategic beta index-based ETF is more costly than the average dividend ETF. FVD shows a 0.70% expense ratio, compared to the average 0.58% expense ratio for dividend yield weighted ETFs and 0.5% expense ratio for the average dividend weighted ETF, according to XTF data. At 0.7%, FVD is twice as expensive as the SPDR S&P Dividend ETF (NYSEARCA: SDY ) and seven times as expensive as the Vanguard Dividend Appreciation ETF (NYSEARCA: VIG ) . First Trust Value Line Dividend Index Fund (click to enlarge) Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. (More…) I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.

More Triple-Leveraged Biotech ETFs Come To Town

Summary New leveraged biotechnology ETFs to hedge or capitalize on market moves. Focus on ProShares’s new leveraged/inverse NASDAQ Biotechnology ETFs. Additionally, ProShares added leveraged/inverse Oil & Gas and homebuilder funds as well. By Todd Shriber & Tom Lydon For over five years, the ProShares Ultrashort Nasdaq Biotechnology (NasdaqGM: BIS ) and the ProShares Ultra Nasdaq Biotechnology (NasdaqGM: BIB ) cornered the market for leveraged biotechnology exchange traded funds. In the span of three weeks, the number of leveraged biotech ETFs has tripled. In late May, Direxion introduced the Direxion Daily S&P Biotech Bull Shares (NYSEArca: LABU ) and the Direxion Daily S&P Biotech Bear Shares (NYSEArca: LABD ) . Today, ProShares, the largest issuer of inverse and leveraged ETFs, launched the UltraPro NASDAQ Biotechnology (NasdaqGM: UBIO) and the UltraPro Short NASDAQ Biotechnology (NasdaqGM: ZBIO) . The UltraPro NASDAQ Biotechnology will attempt to deliver three times the daily performance of the NASDAQ Biotechnology Index while the UltraPro Short NASDAQ Biotechnology will seek to deliver three times the daily inverse performance of that index. The NASDAQ Biotechnology Index is the underlying benchmark for the iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB ) , the largest biotech ETF by assets. Maryland-based ProShares introduced four leveraged ETFs today, including a pair of leveraged homebuilders funds, a niche rival Direxion is also eyeing . The Ultra Homebuilders & Supplies (NYSEArca: HBU) and the UltraShort Homebuilders & Supplies (NYSEArca: HBZ) will offer double leverage on the Dow Jones U.S. Select Home Construction Index. That is the underlying benchmark for the $2.1 billion iShares U.S. Home Construction ETF (NYSEArca: ITB ) . ProShares also introduced two double-leveraged equity-based energy ETFs today. Those new funds are the Ultra Oil & Gas Exploration & Production (NYSEArca: UOP) and the UltraShort Oil & Gas Exploration & Production (NYSEArca: SOP) . UOP will seek to deliver double the daily returns of the S&P Oil & Gas Exploration & Production Select Industry Index while SOP will attempt to deliver double the daily inverse returns of that index. That index is the underlying benchmark for the $1.6 billion SPDR S&P Oil & Gas Exploration & Production ETF (NYSEArca: XOP ) . On May 29, Direxion introduced triple-leveraged answers to XOP , the Direxion Daily S&P Oil & Gas Exploration & Production Bull Shares (NYSEArca: GUSH ) and the Direxion Daily S&P Oil & Gas Exploration & Production Bear Shares (NYSEArca: DRIP ) . NASDAQ Biotech Index Top Holdings as of March 31, 2015 Table Courtesy: ProShares Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. (More…) I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.